NANTHEALTH INC (NH) Stock Analyst Earnings Estimates
NASDAQ:NH - Nasdaq - US6301043054 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 73.17M -5.50% | 62.649M -14.38% | 67.002M 6.95% | |
| EBITDA YoY % growth | -8.77M -8.41% | -25.176M -187.07% | -35.335M -40.35% | |
| EBIT YoY % growth | -25.54M 16.12% | -40.899M -60.14% | -51.327M -25.50% | |
| Operating Margin | -34.91% | -65.28% | -76.61% | |
| EPS YoY % growth | -3.90 -4.00% | -5.55 -42.31% | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.12 92.00% | % | ||
| Q2 2022 Q2Q % growth | -1.50 -25.00% | -1.39 | -0.11 | -7.87% |
| Q1 2022 Q2Q % growth | -1.65 -22.22% | -1.39 | -0.26 | -18.66% |
| Q4 2021 Q2Q % growth | -1.50 -66.67% | -1.31 | -0.19 | -14.22% |
| Q3 2021 Q2Q % growth | -1.50 -42.86% | -1.24 | -0.26 | -21.36% |
| Q2 2021 Q2Q % growth | -1.20 -14.29% | -1.47 | 0.27 | 18.24% |
| Q1 2021 Q2Q % growth | -1.35 -50.00% | -1.16 | -0.19 | -16.50% |
| Q4 2020 Q2Q % growth | -0.90 -50.00% | -1.24 | 0.34 | 27.18% |
| Q3 2020 Q2Q % growth | -1.05 | -1.00 | -0.05 | -4.56% |
| Q2 2020 Q2Q % growth | -1.05 -75.00% | -0.85 | -0.20 | -23.57% |
| Q1 2020 Q2Q % growth | -0.90 40.00% | -1.00 | 0.10 | 10.38% |
| Q4 2019 Q2Q % growth | -0.60 | -0.85 | 0.25 | 29.39% |
| Q3 2019 Q2Q % growth | -1.05 | -0.54 | -0.51 | -94.17% |
| Q2 2019 Q2Q % growth | -0.60 | -1.39 | 0.79 | 56.85% |
| Q1 2019 Q2Q % growth | -1.50 | -1.55 | 0.04 | 2.91% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | 17.05M 4.13% | % | ||
| Q4 2022 Q2Q % growth | 17.498M 9.15% | % | ||
| Q3 2022 Q2Q % growth | 16.633M 15.84% | % | ||
| Q2 2022 Q2Q % growth | 16.498M 2.54% | 17.519M | -1.021M | -5.83% |
| Q1 2022 Q2Q % growth | 16.373M 1.26% | 16.918M | -545K | -3.22% |
| Q4 2021 Q2Q % growth | 16.031M -14.00% | 16.492M | -461K | -2.80% |
| Q3 2021 Q2Q % growth | 14.359M -23.50% | 17.51M | -3.151M | -18.00% |
| Q2 2021 Q2Q % growth | 16.09M -8.53% | 17.096M | -1.006M | -5.88% |
| Q1 2021 Q2Q % growth | 16.17M -11.06% | 18.879M | -2.709M | -14.35% |
| Q4 2020 Q2Q % growth | 18.64M 0.43% | 19.238M | -598K | -3.11% |
| Q3 2020 Q2Q % growth | 18.77M 0.91% | 18.701M | 69K | 0.37% |
| Q2 2020 Q2Q % growth | 17.59M -12.27% | 18.643M | -1.053M | -5.65% |
| Q1 2020 Q2Q % growth | 18.18M -10.04% | 20.858M | -2.678M | -12.84% |
| Q4 2019 Q2Q % growth | 18.56M | 24.371M | -5.811M | -23.84% |
| Q3 2019 Q2Q % growth | 18.6M | 24.708M | -6.108M | -24.72% |
| Q2 2019 Q2Q % growth | 20.05M | 24.479M | -4.429M | -18.09% |
| Q1 2019 Q2Q % growth | 20.21M | 24.804M | -4.594M | -18.52% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |